Two-part Pharmacokinetic and Pharmacodynamic Study of LAS190792 in Patients With Asthma and COPD

Clinical trial NCT02059434 · COMPLETED

Trial details

NCT number: NCT02059434
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Obstructive Pulmonary Disease (COPD)Asthma

Start date: 2013-09-01
Primary completion: 2014-10-06
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.